Provided by Tiger Trade Technology Pte. Ltd.

Orexo AB

3.23
0.0000
Volume:- -
Turnover:- -
Market Cap:111.45M
PE:-5.21
High:3.23
Open:3.23
Low:3.23
Close:3.23
52wk High:3.23
52wk Low:1.90
Shares:34.51M
Float Shares:22.58M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6202
EPS(LYR):-0.7202
ROE:-325.00%
ROA:-15.59%
PB:-4.48
PE(LYR):-4.48

Loading ...

Company Profile

Company Name:
Orexo AB
Exchange:
OTCQX
Establishment Date:
1994
Employees:
104
Office Location:
Rapsgatan 7E,Uppsala,Uppsala County,Sweden
Zip Code:
- -
Fax:
46 1 87 80 88 88
Introduction:
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is also developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 for emergency treatment of allergic reactions; and OX-MPI for the treatment of endometriosis. In addition, its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.